Analytical Scientist
Zealand PharmaOm tjänsten
Does it excite you to work with late-stage analytical development of innovative peptide-based medicines, and do you have a background in analytical science? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague. Your new position As Analytical Scientist on a 12-month maternity cover, you will support late-stage analytical development across Development and Life Cycle Management (LCM) projects. You will be guided by experienced colleagues and gain hands-on experience in analytical work and in collaboration with Contract Development and Manufacturing Organizations (CDMOs). We offer exciting responsibilities: Support analytical late-stage development activities in Development and LCM projects Assist with analytical activities for Drug Substance and Drug Product development, such as stability programs, specifications, extractables and leachable studies, in-use studies, and characterization Support the collaboration with CDMOs through day-to-day communication and follow-up on method transfer, validation, and technical and QC activities Help prepare scientific reports and documentation that meet requirements for pharmaceutical products Assist with scientific input to regulatory documents (NDA/MAA) together with colleagues at Zealand Pharma and CDMOs Take part in the Analytical Development team and learn how analytical work contributes to regulatory approval Your profile We are looking for someone with an analytical mindset who is curious, careful, and eager to learn. You take ownership of your tasks, ask questions when needed, and enjoy working together with others. B.Sc., M.Sc., or PhD in chemistry, biochemistry, pharmaceutical sciences, or a related field Analytical experience from similar role Familiarity with GMP, late-stage development, or peptide-based products is an advantage, but not a requirement Interest in working with external partners such as CDMOs, CMOs, and CROs Good collaboration skills and a structured way of working Good written and verbal communication skills in English Your new team You will join a highly experienced team in Analytical Development, where you will learn from colleagues who share their knowledge. We value a collaborative and supportive atmosphere in which great results are achieved together. Let's bond and be bold We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture. Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold. Interested in bonding with us? Then please apply no later than November 30, 2026, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying. For further information, please contact Director, Head of Analytical Development, Iben Almar Meier; imeier@zealandpharma.com. We are committed to an inclusive recruitment process and welcome applications from all job applicants. About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com. #LI-Onsite Since our founding in 1998, Zealand Pharma has built a core expertise in the discovery, design, and development of therapeutic peptides. This expertise has led to an R&D pipeline of innovative investigational candidates designed to address a broad range of disease areas. We have four therapeutic focus areas: obesity, rare diseases, chronic inflammation, and type 1 diabetes. In obesity, our peptide capabilities place us in a unique position to address a vast global health challenge and positively impact hundreds of millions of lives. Within rare diseases, we have a long-standing commitment to deliver new treatments to patients living with congenital hyperinsulinism and short bowel syndrome. For chronic inflammatory diseases, we are progressing peptide programs focused on high-profile targets shown to be difficult to address with small molecules and antibodies. For type 1 diabetes, we aspire to change the management of this disease. Our strategy is to pursue global co-development and commercialization partnerships that complement and extend our capabilities across the value chain to deliver new peptide therapies to people who need them.
Krav- & nyckelordscheck
Identifierade kompetenser & krav i annonsen:
Har du någon av dessa kompetenser? Klicka på ett ord för att lägga till det i din profil:
Restid & pendling
Spara jobb & deadline-påminnelse
Sista ansökningsdag: 30 nov.Inte redo att söka direkt? Spara annonsen och få påminnelse innan den stänger
När du sparar tjänsten samlas den under Mina sidor (Ansökningskoll) och vi skickar automatiskt en påminnelse på mejlen 3 dagar innan sista ansökningsdag så att du inte missar att söka.
Representerar du arbetsgivaren? Få prioriterad topp-placering i Søborg och dölj konkurrerande annonser på sidan.